Alpha Paradigm Partners, LLC Viatris Inc Transaction History

Alpha Paradigm Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$9.95 - $12.27 $18,029 - $22,233	-1,812 Reduced 21.48%	6,622 $69 Million
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $11,281 - $17,710	1,150 Added 15.79%	8,434 $92 Million
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $88,063 - $106,929	7,284 New	7,284 $99 Million
Q2 2021 Aug 13, 2021	SELL	$12.97 - $16.15 $133,214 - $165,876	-10,271 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$13.59 - $18.54 $139,582 - $190,424	10,271 New	10,271 $143,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.